| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 64.75B | 72.29B | 64.12B | 64.83B | 75.07B | 64.95B |
| Gross Profit | 18.49B | 21.87B | 18.29B | 20.00B | 26.07B | 18.86B |
| EBITDA | 7.61B | 10.67B | 7.03B | 8.19B | 14.28B | 9.23B |
| Net Income | 310.00M | 3.95B | 260.00M | 2.77B | 7.37B | 4.77B |
Balance Sheet | ||||||
| Total Assets | 141.74B | 151.55B | 141.37B | 129.57B | 112.77B | 94.99B |
| Cash, Cash Equivalents and Short-Term Investments | 25.83B | 29.00B | 26.64B | 32.55B | 29.65B | 22.92B |
| Total Debt | 46.06B | 45.41B | 44.99B | 31.84B | 17.49B | 7.21B |
| Total Liabilities | 63.71B | 62.97B | 63.25B | 50.99B | 39.04B | 27.88B |
| Stockholders Equity | 78.03B | 88.58B | 78.11B | 78.57B | 73.72B | 67.10B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.43B | -16.97B | -8.60B | -3.44B | 1.33B |
| Operating Cash Flow | 0.00 | 8.85B | 8.10B | 7.09B | 8.21B | 5.97B |
| Investing Cash Flow | 0.00 | -6.84B | -23.94B | -17.40B | -12.93B | -5.92B |
| Financing Cash Flow | 0.00 | -510.00M | 11.25B | 12.29B | 8.53B | 1.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥5.27T | 19.07 | ― | 1.41% | 13.61% | 17.01% | |
73 Outperform | ¥9.48T | 26.69 | 8.95% | 1.88% | 5.02% | 2.02% | |
69 Neutral | ¥62.49B | 13.59 | 3.68% | 2.19% | 12.74% | 1420.18% | |
67 Neutral | ¥158.27B | 11.45 | ― | 2.18% | -4.77% | -62.32% | |
65 Neutral | ¥771.48B | 15.62 | ― | 2.57% | 5.15% | -47.22% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
45 Neutral | ¥1.24B | -3.17 | ― | 3.16% | -8.50% | -66.56% |